The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gadobutrol (CAS 138071-82-6) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Gadobutrol (CAS 138071-82-6) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gadobutrol (CAS 138071-82-6) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Gadobutrol (CAS 138071-82-6) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gadobutrol (CAS 138071-82-6) include Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, Jilin Tely Imp & Exp, and JinYan Chemicals (ShangHai), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gadobutrol (CAS 138071-82-6) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Market segment by Application can be divided into
Adults
Children
The key market players for global Gadobutrol (CAS 138071-82-6) market are listed below:
Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma
Jilin Tely Imp & Exp
JinYan Chemicals (ShangHai)
BOC Sciences
LGM Pharma
Advanced Technology & Industrail
MedKoo Biosciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gadobutrol (CAS 138071-82-6) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gadobutrol (CAS 138071-82-6), with price, sales, revenue and global market share of Gadobutrol (CAS 138071-82-6) from 2019 to 2022.
Chapter 3, the Gadobutrol (CAS 138071-82-6) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gadobutrol (CAS 138071-82-6) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gadobutrol (CAS 138071-82-6) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gadobutrol (CAS 138071-82-6).
Chapter 13, 14, and 15, to describe Gadobutrol (CAS 138071-82-6) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Gadobutrol (CAS 138071-82-6) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gadobutrol (CAS 138071-82-6) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Gadobutrol (CAS 138071-82-6) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gadobutrol (CAS 138071-82-6) include Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, Jilin Tely Imp & Exp, and JinYan Chemicals (ShangHai), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gadobutrol (CAS 138071-82-6) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Market segment by Application can be divided into
Adults
Children
The key market players for global Gadobutrol (CAS 138071-82-6) market are listed below:
Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma
Jilin Tely Imp & Exp
JinYan Chemicals (ShangHai)
BOC Sciences
LGM Pharma
Advanced Technology & Industrail
MedKoo Biosciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gadobutrol (CAS 138071-82-6) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gadobutrol (CAS 138071-82-6), with price, sales, revenue and global market share of Gadobutrol (CAS 138071-82-6) from 2019 to 2022.
Chapter 3, the Gadobutrol (CAS 138071-82-6) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gadobutrol (CAS 138071-82-6) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gadobutrol (CAS 138071-82-6) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gadobutrol (CAS 138071-82-6).
Chapter 13, 14, and 15, to describe Gadobutrol (CAS 138071-82-6) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Gadobutrol (CAS 138071-82-6) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gadobutrol (CAS 138071-82-6) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.2.3 Pharmacy Bulk Packages (30 mL and 65 mL)
1.3 Market Analysis by Application
1.3.1 Overview: Global Gadobutrol (CAS 138071-82-6) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.4 Global Gadobutrol (CAS 138071-82-6) Market Size & Forecast
1.4.1 Global Gadobutrol (CAS 138071-82-6) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gadobutrol (CAS 138071-82-6) Sales in Volume (2017-2028)
1.4.3 Global Gadobutrol (CAS 138071-82-6) Price (2017-2028)
1.5 Global Gadobutrol (CAS 138071-82-6) Production Capacity Analysis
1.5.1 Global Gadobutrol (CAS 138071-82-6) Total Production Capacity (2017-2028)
1.5.2 Global Gadobutrol (CAS 138071-82-6) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gadobutrol (CAS 138071-82-6) Market Drivers
1.6.2 Gadobutrol (CAS 138071-82-6) Market Restraints
1.6.3 Gadobutrol (CAS 138071-82-6) Trends Analysis
2 Manufacturers Profiles
2.1 Bayer HealthCare Pharmaceuticals
2.1.1 Bayer HealthCare Pharmaceuticals Details
2.1.2 Bayer HealthCare Pharmaceuticals Major Business
2.1.3 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product and Services
2.1.4 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 SWAPNROOP DRUGS & PHARMACEUTICALS
2.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Details
2.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Major Business
2.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product and Services
2.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Manus Aktteva Biopharma
2.3.1 Manus Aktteva Biopharma Details
2.3.2 Manus Aktteva Biopharma Major Business
2.3.3 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product and Services
2.3.4 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jilin Tely Imp & Exp
2.4.1 Jilin Tely Imp & Exp Details
2.4.2 Jilin Tely Imp & Exp Major Business
2.4.3 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product and Services
2.4.4 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 JinYan Chemicals (ShangHai)
2.5.1 JinYan Chemicals (ShangHai) Details
2.5.2 JinYan Chemicals (ShangHai) Major Business
2.5.3 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product and Services
2.5.4 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 BOC Sciences
2.6.1 BOC Sciences Details
2.6.2 BOC Sciences Major Business
2.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Product and Services
2.6.4 BOC Sciences Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 LGM Pharma
2.7.1 LGM Pharma Details
2.7.2 LGM Pharma Major Business
2.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Product and Services
2.7.4 LGM Pharma Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Advanced Technology & Industrail
2.8.1 Advanced Technology & Industrail Details
2.8.2 Advanced Technology & Industrail Major Business
2.8.3 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product and Services
2.8.4 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 MedKoo Biosciences
2.9.1 MedKoo Biosciences Details
2.9.2 MedKoo Biosciences Major Business
2.9.3 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product and Services
2.9.4 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gadobutrol (CAS 138071-82-6) Breakdown Data by Manufacturer
3.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gadobutrol (CAS 138071-82-6)
3.4 Market Concentration Rate
3.4.1 Top 3 Gadobutrol (CAS 138071-82-6) Manufacturer Market Share in 2021
3.4.2 Top 6 Gadobutrol (CAS 138071-82-6) Manufacturer Market Share in 2021
3.5 Global Gadobutrol (CAS 138071-82-6) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gadobutrol (CAS 138071-82-6) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Region
4.1.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Region (2017-2028)
4.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2028)
4.2 North America Gadobutrol (CAS 138071-82-6) Revenue (2017-2028)
4.3 Europe Gadobutrol (CAS 138071-82-6) Revenue (2017-2028)
4.4 Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue (2017-2028)
4.5 South America Gadobutrol (CAS 138071-82-6) Revenue (2017-2028)
4.6 Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Type (2017-2028)
5.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2017-2028)
5.3 Global Gadobutrol (CAS 138071-82-6) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Application (2017-2028)
6.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2017-2028)
6.3 Global Gadobutrol (CAS 138071-82-6) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2028)
7.2 North America Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2028)
7.3 North America Gadobutrol (CAS 138071-82-6) Market Size by Country
7.3.1 North America Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2017-2028)
7.3.2 North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2028)
8.2 Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2028)
8.3 Europe Gadobutrol (CAS 138071-82-6) Market Size by Country
8.3.1 Europe Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2017-2028)
8.3.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2028)
9.2 Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2028)
9.3 Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size by Region
9.3.1 Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2028)
10.2 South America Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2028)
10.3 South America Gadobutrol (CAS 138071-82-6) Market Size by Country
10.3.1 South America Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2017-2028)
10.3.2 South America Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2028)
11.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2028)
11.3 Middle East & Africa Gadobutrol (CAS 138071-82-6) Market Size by Country
11.3.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gadobutrol (CAS 138071-82-6) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gadobutrol (CAS 138071-82-6)
12.3 Gadobutrol (CAS 138071-82-6) Production Process
12.4 Gadobutrol (CAS 138071-82-6) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gadobutrol (CAS 138071-82-6) Typical Distributors
13.3 Gadobutrol (CAS 138071-82-6) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Gadobutrol (CAS 138071-82-6) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gadobutrol (CAS 138071-82-6) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer HealthCare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Bayer HealthCare Pharmaceuticals Major Business
Table 5. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product and Services
Table 6. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. SWAPNROOP DRUGS & PHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 8. SWAPNROOP DRUGS & PHARMACEUTICALS Major Business
Table 9. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product and Services
Table 10. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Manus Aktteva Biopharma Basic Information, Manufacturing Base and Competitors
Table 12. Manus Aktteva Biopharma Major Business
Table 13. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product and Services
Table 14. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Jilin Tely Imp & Exp Basic Information, Manufacturing Base and Competitors
Table 16. Jilin Tely Imp & Exp Major Business
Table 17. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product and Services
Table 18. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. JinYan Chemicals (ShangHai) Basic Information, Manufacturing Base and Competitors
Table 20. JinYan Chemicals (ShangHai) Major Business
Table 21. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product and Services
Table 22. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 24. BOC Sciences Major Business
Table 25. BOC Sciences Gadobutrol (CAS 138071-82-6) Product and Services
Table 26. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. LGM Pharma Basic Information, Manufacturing Base and Competitors
Table 28. LGM Pharma Major Business
Table 29. LGM Pharma Gadobutrol (CAS 138071-82-6) Product and Services
Table 30. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Advanced Technology & Industrail Basic Information, Manufacturing Base and Competitors
Table 32. Advanced Technology & Industrail Major Business
Table 33. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product and Services
Table 34. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. MedKoo Biosciences Basic Information, Manufacturing Base and Competitors
Table 36. MedKoo Biosciences Major Business
Table 37. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product and Services
Table 38. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales (M L), Price (USD/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Gadobutrol (CAS 138071-82-6) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M L)
Table 40. Global Gadobutrol (CAS 138071-82-6) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Gadobutrol (CAS 138071-82-6), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Gadobutrol (CAS 138071-82-6) Production Capacity by Company, (M L): 2020 VS 2021
Table 43. Head Office and Gadobutrol (CAS 138071-82-6) Production Site of Key Manufacturer
Table 44. Gadobutrol (CAS 138071-82-6) New Entrant and Capacity Expansion Plans
Table 45. Gadobutrol (CAS 138071-82-6) Mergers & Acquisitions in the Past Five Years
Table 46. Global Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022) & (M L)
Table 47. Global Gadobutrol (CAS 138071-82-6) Sales by Region (2023-2028) & (M L)
Table 48. Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 51. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2023-2028) & (M L)
Table 52. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Gadobutrol (CAS 138071-82-6) Price by Type (2017-2022) & (USD/L)
Table 55. Global Gadobutrol (CAS 138071-82-6) Price by Type (2023-2028) & (USD/L)
Table 56. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 57. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2023-2028) & (M L)
Table 58. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Gadobutrol (CAS 138071-82-6) Price by Application (2017-2022) & (USD/L)
Table 61. Global Gadobutrol (CAS 138071-82-6) Price by Application (2023-2028) & (USD/L)
Table 62. North America Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 63. North America Gadobutrol (CAS 138071-82-6) Sales by Country (2023-2028) & (M L)
Table 64. North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 67. North America Gadobutrol (CAS 138071-82-6) Sales by Type (2023-2028) & (M L)
Table 68. North America Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 69. North America Gadobutrol (CAS 138071-82-6) Sales by Application (2023-2028) & (M L)
Table 70. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 71. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2023-2028) & (M L)
Table 72. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 75. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2023-2028) & (M L)
Table 76. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 77. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2023-2028) & (M L)
Table 78. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022) & (M L)
Table 79. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2023-2028) & (M L)
Table 80. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 83. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Type (2023-2028) & (M L)
Table 84. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 85. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Application (2023-2028) & (M L)
Table 86. South America Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 87. South America Gadobutrol (CAS 138071-82-6) Sales by Country (2023-2028) & (M L)
Table 88. South America Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Gadobutrol (CAS 138071-82-6) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 91. South America Gadobutrol (CAS 138071-82-6) Sales by Type (2023-2028) & (M L)
Table 92. South America Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 93. South America Gadobutrol (CAS 138071-82-6) Sales by Application (2023-2028) & (M L)
Table 94. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022) & (M L)
Table 95. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Region (2023-2028) & (M L)
Table 96. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 99. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2023-2028) & (M L)
Table 100. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 101. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2023-2028) & (M L)
Table 102. Gadobutrol (CAS 138071-82-6) Raw Material
Table 103. Key Manufacturers of Gadobutrol (CAS 138071-82-6) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Gadobutrol (CAS 138071-82-6) Typical Distributors
Table 107. Gadobutrol (CAS 138071-82-6) Typical Customers
List of Figures
Figure 1. Gadobutrol (CAS 138071-82-6) Picture
Figure 2. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type in 2021
Figure 3. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Figure 4. Pharmacy Bulk Packages (30 mL and 65 mL)
Figure 5. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application in 2021
Figure 6. Adults
Figure 7. Children
Figure 8. Global Gadobutrol (CAS 138071-82-6) Revenue, (USD Million) & (M L): 2017 & 2021 & 2028
Figure 9. Global Gadobutrol (CAS 138071-82-6) Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Gadobutrol (CAS 138071-82-6) Sales (2017-2028) & (M L)
Figure 11. Global Gadobutrol (CAS 138071-82-6) Price (2017-2028) & (USD/L)
Figure 12. Global Gadobutrol (CAS 138071-82-6) Production Capacity (2017-2028) & (M L)
Figure 13. Global Gadobutrol (CAS 138071-82-6) Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Gadobutrol (CAS 138071-82-6) Market Drivers
Figure 15. Gadobutrol (CAS 138071-82-6) Market Restraints
Figure 16. Gadobutrol (CAS 138071-82-6) Market Trends
Figure 17. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Manufacturer in 2021
Figure 18. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Manufacturer in 2021
Figure 19. Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Gadobutrol (CAS 138071-82-6) Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Gadobutrol (CAS 138071-82-6) Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2028)
Figure 23. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2017-2028)
Figure 24. North America Gadobutrol (CAS 138071-82-6) Revenue (2017-2028) & (USD Million)
Figure 25. Europe Gadobutrol (CAS 138071-82-6) Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue (2017-2028) & (USD Million)
Figure 27. South America Gadobutrol (CAS 138071-82-6) Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue (2017-2028) & (USD Million)
Figure 29. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2028)
Figure 30. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2017-2028)
Figure 31. Global Gadobutrol (CAS 138071-82-6) Price by Type (2017-2028) & (USD/L)
Figure 32. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2028)
Figure 33. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2017-2028)
Figure 34. Global Gadobutrol (CAS 138071-82-6) Price by Application (2017-2028) & (USD/L)
Figure 35. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2028)
Figure 36. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2028)
Figure 37. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2028)
Figure 38. North America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2028)
Figure 39. United States Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2028)
Figure 43. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2028)
Figure 44. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2028)
Figure 45. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2028)
Figure 46. Germany Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2017-2028)
Figure 55. China Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2028)
Figure 62. South America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2028)
Figure 63. South America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2028)
Figure 64. South America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Gadobutrol (CAS 138071-82-6) in 2021
Figure 76. Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
Figure 77. Gadobutrol (CAS 138071-82-6) Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
